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GISTs arise from mesenchymal precursor cells of the
gastrointestinal tract that may differentiate towards the
interstitial cells of Cajal, pacemaker cells regulating
autonomous motility of G.I. tract.
About 60% of GISTs are found in the stomach,
20e50% in the small bowel (one third in the duodenum),
and 5e15% in colon and rectum; GISTs, however, may rarely
be found also in the oesophagus, omentum, mesentery or
the retroperitoneum.
The distribution of these tumors in the stomach is: pars
media, 40%; antrum, 25%; pylorus, 20%. In less than 15%,
GISTs location is next to the EGJ, in the cardia and in the
fundus.1,2
Gastric GISTs may also present as pedunculated, exo-
phytic masses. This pattern of growth is rare, and diagnosis
is often made after surgery, since the lack of specific
symptoms.3e76 49972197.
@uniroma1.it (G. Cavallaro).
7 Surgical Associates Ltd. PublishThe Authors report two cases of pedunculated gastric
GIST with totally extraluminal growth.
Case reports
Case 1
A 72-year-old man suffering from arterial hypertension and
type II diabetes mellitus was referred to our institution for
abdominal pain and weight loss. Clinical examination
revealed a large palpable mass located in the epigastric
region. Upper G-I endoscopy showed no abnormalities. CT
scan revealed a large abdominal mass extending from the
diaphragm to the left flank, displacing the small bowel to
the right and the stomach anteriorly (Fig. 1).
At surgery a large mass occupying the abdominal cavity
was found. The tumor was located between the stomach
and the transverse mesocolon. The mass was isolated from
the surrounding structures, and it was found to take origin
from the larger gastric curvature, having a short pedicle.
The tumor was completely excised with a small portion of
the gastric wall surrounding the pedicle.ed by Elsevier Ltd. All rights reserved.
Figure 1 CT scan reveals a large abdominal mass extending
from the diaphragm to the left flank. Figure 2 CT scan reveals a sub-diaphragmatic mass extended
from the left hepatic lobe to the pelvis, with small bowel and
stomach dislocation.
Figure 3 Intraoperative view of the tumor.
Pedunculated gastric GIST e81The specimen was 15.5 13 9.5 cm in size. The cut sur-
face revealed thepresenceofnecroticandhemorrhagicareas.
Histology showed the presence of epithelioid cells
arranged in interlacing bundles, with round nuclei. There
was high cellularity and pleomorphism with focal necrosis
and hemorrhage. Mitotic index was high (10e15/50 hpf).
Immunohistochemistry showed positive reaction to CD117
(c-kit), CD34, Vimentin. So the tumor was diagnosed as high-
risk GIST. The gastric wall excised showed no infiltration.
Postoperative course was uneventful, and the patient
was discharged on p.o. day 10.
The patient did not received adjuvant chemotherapy or
Imatinib, since the lack of disease residual.
Follow-up was carried out by clinical examination at 1
month and US-scan at 1, 6 and 12 months after surgery, and
CT-scan at 3 and 12 months after surgery.
After one-year follow-up the patient is doing well and he
has no signs of disease recurrence.
Case 2
A 63-year-old man was referred to our institution for
evidence of abdominal mass. CT scan revealed a sub-
diaphragmatic mass extended from the left hepatic lobe
to the pelvis, with small bowel and stomach dislocation
(Fig. 2). Upper G-I endoscopy did not show abnormalities.
At surgery a large mass (Fig. 3) occupying the abdominal
cavity was found. This tumor displaced the transverse colon
and small bowel on the left side, and the stomach anteri-
orly. The lesion originated from the posterior gastric wall,
by a short pedicle. It was completely excised with the
greater omentum and a small portion of the gastric wall.
The specimen was 19 17.5 12.5 cm in size. The cut
surface revealed the presence of necrotic and hemorrhagic
areas.
Histology showed of spindle-shaped cells arranged in
interlacing bundles. There was high cellularity and pleo-
morphism with focal necrosis and hemorrhage. Mitotic
index was high (18/50 hpf). Immunohistochemistry showed
reaction to CD117 (c-kit) and CD34 (Fig. 4). So the tumor
was diagnosed as high-risk GIST.Postoperative course was uneventful, and the patient
was discharged on p.o. day 8.
The patient did not receive adjuvant chemotherapy or
Imatinib, due to the lack of disease residual.
Follow-up was carried out by clinical examination at 1
month and US-scan at 1, 6 and 12 months after surgery, and
CT-scan at 3, 12 and 18 months after surgery.
After 18-months follow-up the patient is doing well and
he has no signs of disease recurrence.
Discussion
GIST account for approximately 1% of gastric neoplasms.8,9
About 60% of GISTs are submucosal; 30% are subserosal and
10% are intramural. Sometimes GISTs may present as large
pedunculated extragastric lesion.
Some of these lesions present cystic change, and this
may be the consequence of a rapid tumor growth, with
congestion and intratumoral hemorrage.6,7
Figure 4 Immunohistochemistry shows positive reaction to
CD-117 (c-kit).
e82 G. Cavallaro et al.Diagnosis is often made only after surgery, since the
presence of large abdominal mass can rarely be identified
preoperatively as a gastric tumor.
Instrumental examination may include Upper G-I endos-
copy, CT scan, MRI and even endoscopic ultrasonography.
This technique permits to distinguish mesenchymal tumors
from other kinds of tumors, and even benign from malig-
nant mesenchymal lesions.10 Furthermore, EUS-guided fine-
needle aspiration biopsy can lead to a precise clinical
diagnosis.11
According to the current pathologic and prognostic
classifications,12e14 these pedunculated lesions are often
classified as lesions having high risk of malignancy (due to
the large dimension and the high number of mitoses) even
if they use to have only expansive growth, without infiltra-
tion of surrounding structures.7
For this reason the treatment of choice is extensive
surgical resection of the tumor with a wedge resection of
the stomach at the level of the tumor pedicle. Patients who
have complete tumor resection (R0) have more favorable
outcome than those with less complete surgery.
Incomplete surgical resection should be performed
only for the palliation of symptoms due to bleeding,
pain or mass effect. Non-resectable or metastatic GIST is
a fatal disease that resist conventional chemotherapy or
radiotherapy.12,15,16
Treatment with Imatinib seems to be the best systemic
therapy for metastatic and locally advanced GISTs.
The high response rates with Imatinib in advanced and
metastatic setting have fostered interest in its role even in
the adjuvant or preoperative settings. There may be an
improvement in surgical outcome in patients treated with
Imatinib preoperatively. Currently, there are several trials
to address combining surgery and Imatinib.15e17
In conclusion the clinical presentation of pedunculated
gastric GISTs as large abdominal masses should request
extensive R0 surgery, and strict post-operative follow-up,
and even post-surgical treatment with selective kit-inhib-
itors, due to the elevated risk of malignancy.Conflict of interest: None.
Funding: None.
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